Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$20M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 25 most recent Form 4 transactions.
| Jun 17 | KARD | Kardigan, Inc. | CCONV◆ | 2.3M | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | KARD | Kardigan, Inc. | CCONV◆ | 1.2M | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | KARD | Kardigan, Inc. | CCONV◆ | 5.1M | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | KARD | Kardigan, Inc. | AGRANT | 20,706 | — | — | — | Open the original filing on SEC.gov |
| Jun 17 | KARD | Kardigan, Inc. | CCONV | 13.8M | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | NMRA | Neumora Therapeutics, Inc. | SSELL | 9,819 | $3.51 | $34.5K | -0.1% | Open the original filing on SEC.gov |
| Jan 8 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 1.7M | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS◆ | 223,430 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS◆ | 24,188 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | AGRANT◆ | 4,031 | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 957,559 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 8.3M | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 7.5M | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 4,031 | — | — | -100.0% | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 342,500 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 955,864 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | AGRANT◆ | 497,049 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 2M | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 342,500 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 955,864 | — | — | — | Open the original filing on SEC.gov |
| May 28, 2025 | NMRA | Neumora Therapeutics, Inc. | DTOISS◆ | 497,049 | — | — | — | Open the original filing on SEC.gov |
| May 20, 2025 | MTSR | Metsera, Inc. | AGRANT◆ | 24,188 | — | — | — | Open the original filing on SEC.gov |